20 completed, 16 unknown, 4 terminated, 1 recruiting. 41 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 41 | Completed 20, Unknown 16, Terminated 4, Recruiting 1 |
Follow Triptorelin Pamoate: new trials by email Literature Review of Triptorelin Pamoate trials Research Report on Triptorelin Pamoate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis Triptorelin (GnRH agonists), Hormone Replacement Therapy (HRT) - Deep Infiltrating Endometriosis (DIE), Infertility | Phase 4 | Recruiting | Li-jun Ding | 120 | 2025-08-01 | 2026-07-10 |
| Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support gonadotropin releasing hormone-agonist, Progesterone - Female Infertility | Phase 4 | Completed | Alexandria University | 75 | 2022-03-17 | 2025-01-29 |
| Comparison of Triggers in Double Ovarian Stimulation (DuoStim). Triptorelin acetate (a-GnRH), Ovitrelle® (hCG), Decapeptyl 0.1 mg® (a-GnRH) and Ovitrelle® (hCG) used together - IVF, LOW OVARIAN RESPONSE | Phase 4 | Unknown | Instituto Bernabeu | 165 | 2022-03-03 | 2022-04-11 |
| Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2020-08-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Infertility | Phase 4 | Completed | Damascus University | 50 | 2020-08-22 | 2023-10-24 |
| Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients Leuprorelin, Goserelin, Triptorelin - Prostatic Neoplasms | Phase 4 | Unknown | Wonju Severance Christian Hospital | 164 | 2020-01-23 | 2021-07-29 |
| Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes. Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2019-12-22 | 2023-10-24 |
| Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients. Triptorelin acetate, Cetrorelix, recombinant-FSH or recombinant-FSH + human Menopausal Gonadotropin - In Vitro Fertilization, Intracytoplasmic Sperm Injection | Phase 4 | Completed | Damascus University | 50 | 2019-12-22 | 2023-10-24 |
| The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation Triptorelin acetate - Infertility, Female | Phase 4 | Unknown | Peking University People's Hospital | 1892 | 2019-02-01 | 2019-01-18 |
| Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI Triptorelin, cetrorelix, Recombinant Follicle Stimulating Hormone - Invitro Fertilization | Phase 4 | Completed | Cairo University | 204 | 2017-04-21 | 2017-11-07 |
| The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies Triptorelin - Sterility, Infertility | Phase 4 | Completed | American University of Beirut Medical Center | 277 | 2017-03-01 | 2023-07-20 |
| Effects of Sex Steroids on the Serotonin System Testosterone, Lynestrenol, Cyproterone Acetate - Gender Dysphoria | Phase 4 | Unknown | Medical University of Vienna | 92 | 2017-02-06 | 2018-10-15 |
| Luteal Phase Support in Insemination Cycles Triptorelin - Infertility, Female | Phase 4 | Completed | Tampere University Hospital | 167 | 2017-01-01 | 2020-01-27 |
| GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Triptorelin - Infertility | Phase 4 | Unknown | Mansoura University | 200 | 2016-09-09 | 2023-10-30 |
| Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI induction with aromataze inhibitor, HMG, GnRh a - Infertility Indicated for ICSI | Phase 4 | Completed | Minia University | 50 | 2016-08-12 | 2017-09-06 |
| GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles Triptorelin - Infertility | Phase 4 | Unknown | Mansoura University | 200 | 2016-08-07 | 2023-10-30 |
| Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles combined oral contaraceptive pills, recombinant FSH, Urinaru gonadotropin - Assisted Reproduction | Phase 4 | Completed | Cairo University | 160 | 2016-07-20 | 2019-07-05 |
| Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study Choriogonadotropin alfa, Triptorelin acetate - Embryo Transfer, Luteal Support | Phase 4 | Unknown | Sheba Medical Center | 62 | 2016-07-01 | 2016-12-13 |
| Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration GnRHa and HCG, GnRHa then HCG (single low-dose), GnRHa then HCG (multiple low-doses) - Infertility | Phase 4 | Unknown | Mansoura University | 225 | 2016-06-06 | 2023-10-30 |
| the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer . triptorelin 0.1, E2, Progesterone - Infertility | Phase 4 | Unknown | Chong Qing Reproducive and Genetic Institute | 700 | 2015-12-01 | 2016-01-13 |
Showing 20 of 41. Sign in to see all of them.
Infertility (17) · Prostatic Neoplasms (6) · Infertility, Female (4) · Ovarian Hyperstimulation Syndrome (3) · Polycystic Ovary Syndrome (3) · Endometriosis (2) · Aneuploidy (1) · Fatty Liver (1) · Gender Dysphoria (1) · Hypogonadism (1) · Metabolic Syndrome (1) · Neoplasms (1) · Primary Ovarian Insufficiency (1) · Puberty, Precocious (1)
Damascus University (4) · Eugonia (3) · Mansoura University (3) · Bioroma (2) · Cairo University (2) · Ipsen (2) · Alexandria University (1) · American University of Beirut Medical Center (1) · Bart CJM Fauser (1) · Belgian Study Group for Pediatric Endocrinology (1) · Chong Qing Reproducive and Genetic Institute (1) · Elisha Hospital (1) · HaEmek Medical Center, Israel (1) · Herlev Hospital (1) · IVI Madrid (1)
Egypt (7) · Israel (4) · Spain (4) · Syria (4) · China (3) · Greece (3) · Italy (3) · United Kingdom (2) · United States (2) · Austria (1) · Belgium (1) · Denmark (1) · Finland (1) · Lebanon (1) · Netherlands (1)
Abdul Hakim Nattouf, MD, PhD (4) · Marwan Alhalabi, MD, PhD (4) · Sally Kadoura, B Pharm, MD (4) · Mohamed S Abdelhafez, Dr (3) · Tryfon Lainas, PhD (3) · Waleed El-refaie, Dr (2) · Ahmed Abdel Aziz, PhD (1) · Ahmed Maged, MD (1) · Alfonso Bermejo, MD (1) · Giuseppe Saggese, MD (1) · Helena Tinkanen (1)
PMID 11937133, PMID 18403419, PMID 20008886, PMID 24354113, PMID 25296696, PMID 25311972, PMID 25331066, PMID 27567429, PMID 28601378, PMID 28993105, PMID 30609935, PMID 32208810, PMID 32290838, PMID 33011968, PMID 36375827, PMID 37008942, PMID 38216784
2016 (1)